肺神经内分泌肿瘤的生长抑素受体表达:DOTATATE PET 扫描分析
该回顾性机构分析纳入2017年3月至2023年2月接受DOTATATE PET显像的48例转移性肺神经内分泌肿瘤患者,其中4例SSTR表达完全阴性、10例表达极弱(低于正常肝脏),余34例中21例均匀阳性、13例异质性表达,仅44%为均匀阳性。作者认为多数转移性肺NET缺乏均匀SSTR表达,不是SSTR靶向治疗的理想候选者。
要点
- 48例转移性肺NET中4例SSTR完全阴性、10例表达极弱(低于正常肝脏)。
- 余34例中21例DOTATATE PET均匀阳性,13例为异质性表达。
- 仅44%为均匀阳性,可确定为肽受体放射性核素治疗的候选者。
核心结论
- 作者认为多数转移性肺NET缺乏均匀SSTR表达,因此不是SSTR靶向治疗的理想候选者。
- 作者认为肺NET的SSTR显像应仔细评估表达的均匀性。
研究设计与样本
- 对2017年3月至2023年2月接受DOTATATE PET显像的转移性肺NET患者进行回顾性机构分析。
- 共识别48例接受68Ga-或64Cu-DOTATATE PET显像的转移性肺NET患者。
主要发现
- 48例中4例SSTR表达完全阴性,10例表达极弱(低于正常肝脏)。
- 余34例中21例DOTATATE PET均匀阳性,13例为异质性表达。
- 仅44%的患者为均匀阳性受体表达。
关键数值与推荐
- SSTR表达极弱定义为低于正常肝脏。
- 均匀阳性受体表达者被确定为肽受体放射性核素治疗的候选者。
临床怎么用
- 作者认为肺NET的SSTR显像应仔细评估表达的均匀性。
- 均匀阳性受体表达者被确定为肽受体放射性核素治疗的候选者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Somatostatin receptor (SSTR) expression in metastatic lung neuroendocrine tumors (NETs) has not been well characterized using PET imaging. Understanding the degree and uniformity of SSTR expression is important to establish the role of SSTR-targeted treatments in lung NETs. Methods: A retrospective institutional review of patients with metastatic lung NETs who underwent DOTATATE PET imaging from March 2017 to February 2023 was performed. Results: In total, 48 patients with metastatic lung NETs who underwent 68Ga- or 64Cu-DOTATATE PET imaging were identified. Four had completely negative SSTR expression, and 10 had very weak expression (less than in a normal liver). Among the remaining 34 patients, 21 had uniformly positive DOTATATE PET scans, and 13 had heterogeneous expression. Only 44% had uniformly positive receptor expression, identifying them as candidates for peptide receptor radionuclide therapy. Conclusion: Most metastatic lung NETs lack uniform SSTR expression and are thus suboptimal candidates for SSTR-targeted therapy. SSTR imaging in lung NETs should be evaluated carefully for uniformity of expression.
引用
- Al-Toubah T, Montilla-Soler J, El-Haddad G, et al. Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans. J Nucl Med. 2023. PMID: 37797976. doi:10.2967/jnumed.123.266185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。